Hasil Pencarian - Chang-Peng Wu

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    A robust semi-supervised NMF model for single cell RNA-seq data

    A robust semi-supervised NMF model for single cell RNA-seq data oleh Peng Wu, Mo An, Hai-Ren Zou, Cai-Ying Zhong, Wei Wang, Chang-Peng Wu

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma

    Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma oleh Peng Wu, Jia-Li Liu, Shi-Mei Pei, Chang-Peng Wu, Kai Yang, Shu-Peng Wang, Song Wu

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development

    Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development oleh Hua-fu Zhao, Jing Wang, Wei Shao, Chang-peng Wu, Zhong-ping Chen, Shing-shun Tony To, Wei-ping Li

    Diterbitkan 2017-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation

    Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility... oleh Hua-fu Zhao, Chang-peng Wu, Xiu-ming Zhou, Peng-yu Diao, Yan-wen Xu, Jing Liu, Jing Wang, Xian-jian Huang, Wen-lan Liu, Zhong-ping Chen, Guo-dong Huang, Wei-ping Li

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation

    Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma... oleh Hua‑fu Zhao, Chang‑peng Wu, Xiu‑ming Zhou, Peng‑yu Diao, Yan‑wen Xu, Jing Liu, Jing Wang, Xian‑jian Huang, Wen‑lan Liu, Zhong‑ping Chen, Guo‑dong Huang, Wei‑ping Li

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients

    Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients oleh Hua-fu Zhao, Xiu-ming Zhou, Jing Wang, Fan-fan Chen, Chang-peng Wu, Peng-yu Diao, Lin-rong Cai, Lei Chen, Yan-wen Xu, Jing Liu, Zong-yang Li, Wen-lan Liu, Zhong-ping Chen, Guo-dong Huang, Wei-ping Li

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: